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Abstract
Regular exercise plays an important role in the prevention and treatment of
type 2 diabetes (T2D). The synthesis and secretion of myokines in response to
contraction may contribute to the beneficial metabolic effects of exercise.
However, some exercise-induced responses may be attenuated in T2D. Here,
we investigated whether the effect of acute exercise on selected myokines are
impaired in T2D. Skeletal muscle biopsies and blood samples were obtained
from 13 men with T2D and 14 weight-matched, glucose-tolerant men before,
immediately after and 3-h after acute exercise (60 min cycling) to examine
muscle expression and plasma/serum levels of selected myokines. One-hour of
exercise increased muscle expression of IL6, FGF21, ANGPTL4, CHI3L1, CTGF
and CYR61, of which FGF21, ANGPTL4 and CHI3L1 increased further 3-h
into recovery, whereas expression of IL6, CYR61, and CTGF returned to base-
line levels. There was no immediate effect of exercise on IL15 expression, but
it decreased 3-h into recovery. Plasma IL-6 increased robustly, whereas circu-
lating levels of FGF21, ANGPTL4, IL-15, and CHI3L1 increased only modestly
in response to exercise. All returned toward baseline levels 3-h into recovery
except for plasma ANGPTL4, which increased further. No significant differ-
ences in these responses to exercise were observed between the groups. Our
results demonstrate that muscle expression and circulating levels of selected
known and putative myokines were equally regulated by acute exercise in
patients with T2D and weight-matched controls. This suggests that the poten-
tial beneficial metabolic effects of these myokines are not impaired in patients
with T2D.
Introduction
Insulin resistance is an important hallmark in the patho-
genesis of type 2 diabetes (T2D). Skeletal muscle insulin
resistance is characterized by defective insulin signaling to
glucose transport and glycogen synthesis, increased lipid
accumulation, and mitochondrial dysfunction (Szendroedi
et al. 2011; Hojlund 2014; Ritter et al. 2015). Physical
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inactivity increases the risk of developing T2D, while regu-
lar exercise can delay or prevent the onset of T2D (Helm-
rich et al. 1991; Hawley 2004; Madden 2013). Exercise is
associated with numerous beneficial metabolic effects
including improved maximal pulmonary oxygen uptake
(VO2max), insulin sensitivity, and whole-body glucose and
lipid metabolism (Hawley 2004; Hawley et al. 2014).
Accordingly, regular exercise activates various key meta-
bolic pathways leading to enhanced abundance of proteins
involved in insulin-signaling, lipid and glucose metabolism,
and mitochondrial oxidative metabolism (Egan and Zierath
2013). However, some studies have reported attenuated
exercise-mediated increases in insulin sensitivity, VO2max
and muscle expression of markers of mitochondrial oxida-
tive metabolism in individuals with prediabetes and T2D
indicating the existence of exercise resistance (De Filippis
et al. 2008; Hernandez-Alvarez et al. 2010; Stephens and
Sparks 2015). Skeletal muscle is now widely accepted as an
endocrine organ, which in response to contraction and
other stimuli synthesizes and secretes peptides or proteins,
termed myokines (Pedersen et al. 2007; Eckardt et al.
2014). Exercise-induced release of myokines is of great
interest, as myokines may play important roles in muscle
physiology and metabolism, potentially mediating several
beneficial metabolic effects by communicating with other
tissues in an autocrine, paracrine, and endocrine manner
(Pedersen and Febbraio 2012). However, to what extent
production and release of myokines from skeletal muscle in
response to acute exercise are impaired in patients with
T2D remains to be established.
Recently, secretome analysis has led to the identification
of hundreds of putative myokines induced by contraction
in myotubes and human skeletal muscle (Catoire et al.
2014a; Hartwig et al. 2014; Pourteymour et al. 2017).
However, the physiological function, regulation and
whether these myokines are released from human skeletal
muscle in vivo remain unclear. One of the most well-estab-
lished myokines is interleukin 6 (IL-6), which is robustly
induced and released from human skeletal muscle in
response to acute exercise and exercise training (Steensberg
et al. 2000; Keller et al. 2003; Christiansen et al. 2013; Lan-
gleite et al. 2016). The muscle expression and secretion of
IL-6 is dependent upon exercise intensity, duration and
pre-exercise glycogen content (Steensberg et al. 2000,
2001). Moreover, there is experimental evidence that IL-6
may contribute to the insulin-sensitizing and anti-inflam-
matory effects of exercise, at least in healthy humans
(Carey et al. 2006). However, IL-6 infusion into patients
with T2D did not improve insulin sensitivity (Harder-
Lauridsen et al. 2014). Interleukin-15 (IL-15) is another
presumed myokine, which is believed to play a role in
muscle growth, lipid and glucose metabolism, enhanced
mitochondrial function and reduced fat mass (Duan et al.
2017). Acute exercise has been shown to increase the circu-
lating levels of IL-15 in healthy, lean, and obese individuals
(Riechman et al. 2004; Tamura et al. 2011; Christiansen
et al. 2013). Less consistently, studies have shown either
increased (Louis et al. 2007) or no change (Nieman et al.
2003, 2004) in skeletal muscle expression of IL15 after
acute endurance exercise in healthy subjects.
Newly identified putative myokines include angiopoi-
etin-like 4 (ANGPTL4), chitinase 3-like protein 1
(CHI3L1), and fibroblast growth factor 21 (FGF21),
which are believed to play key roles in glucose and lipid
metabolism, muscle growth and inflammation (Grootaert
et al. 2012; Fisher and Maratos-Flier 2016; Gorgens et al.
2016) as well as cysteine rich angiogenic inducer 61
(CYR61) and connective tissue growth factor (CTGF),
which are involved in angiogenesis and remodeling of
extracellular matrix (ECM) within skeletal muscle (Perbal
2004; Catoire et al. 2014a; Pourteymour et al. 2017).
ANGPTL4 regulates lipid metabolism by inhibiting
lipoprotein lipase (LPL) activity (Grootaert et al. 2012),
while FGF21 is a member of the fibroblast growth factor
superfamily, which among many proposed biological
functions also has been described as a putative myokine
and currently is being pursued as a therapeutic drug for
obesity and T2D (Fisher and Maratos-Flier 2016).
CHI3L1 (or YKL-40) is a glycoprotein, which has been
reported to inhibit TNFa-induced inflammation and
insulin resistance in human skeletal muscle cells (Gorgens
et al. 2014). Several studies in mice and healthy humans
have shown increased muscle gene expression and circu-
lating levels of CHI3L1 and ANGPTL4 in response to
acute exercise (Kersten et al. 2009; Catoire et al. 2014a,b;
Gorgens et al. 2016; Ingerslev et al. 2017). Some (Ozaki
et al. 2005; Catoire et al. 2014b), but not all studies (Kim
et al. 2013) in mice and healthy humans have observed
increased muscle gene expression of FGF21 in response
to acute exercise, whereas circulating levels of FGF21 are
consistently reported to be increased in response to acute
exercise (Kim et al. 2013; Hansen et al. 2016; Tanimura
et al. 2016). For most novel putative myokines, it
remains to be established whether skeletal muscle is the
major origin of the exercise-induced increase in circulat-
ing levels. Moreover, the circulating levels of IL-6,
CHI3L1, and FGF21 and less consistently ANGPTL4 have
been reported to be elevated in patients with T2D and
other insulin resistant conditions in the resting, fasting
state (Duncan et al. 2003; Nielsen et al. 2008; Chavez
et al. 2009; Cheng et al. 2011; Kruse et al. 2017; Tjeer-
dema et al. 2014; Xu et al. 2005). Together with the
reported existence of exercise resistance in some cohorts
of insulin resistant individuals, these observations suggest
that the exercise-mediated regulation of these known and
putative myokines may be altered in patients with T2D.
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In line, an attenuated exercise-induced increase in plasma
FGF21 in patients with T2D was recently reported (Han-
sen et al. 2016).
The aim of the present study was to test the hypothesis
that the exercise-induced changes in muscle gene expres-
sion and circulating levels of selected known and putative
myokines were attenuated in patients with T2D compared
with weight-matched controls, and whether the exercise-
induced changes in muscle expression and circulating
levels of myokines were co-regulated or correlated with
body composition and metabolic characteristics.
Materials and Methods
Subjects
In the present study, we investigated skeletal muscle biop-
sies and blood samples from a larger study of the effects of
insulin and acute exercise (Pedersen et al. 2015; Kjobsted
et al. 2016; Kruse et al. 2016). In brief, 13 overweight/obese
male type 2 diabetic patients and 14 obese, nondiabetic
male control individuals group-wise matched for age, BMI
and self-reported physical activity level (IPAQ) were
recruited (Table 1). The type 2 diabetic patients were
GAD65-antibody negative and without signs of diabetic
micro- or macrovascular complications. The control indi-
viduals had normal fasting glucose, normal glucose toler-
ance, and no family history of diabetes. The patients with
T2D were treated either by diet alone (n = 4) or by diet in
combination with metformin (n = 5) or metformin and
sulfonylurea (n = 4). Seven days before each study day, all
medications were withdrawn. Forty-eight hours before each
study day, the participants were instructed to avoid strenu-
ous exercise. Informed consent was obtained from all par-
ticipants before participation. The study was approved by
The Regional Scientific Ethical Committees for Southern
Denmark and was performed in accordance with the Hel-
sinki Declaration.
Experimental design
One week before the first experimental trial, all participants
underwent blood screening tests, ECG and exercise tests to
determine maximal workload (Wmax) capacity and maxi-
mal aerobic capacity (VO2max) as previously reported (Ped-
ersen et al. 2015; Kjobsted et al. 2016; Kruse et al. 2016).
All the participants underwent a baseline euglycemic-
hyperinsulinemic clamp and an exercise day separated by
4–8 weeks. After an overnight fast, the participants (base-
line day) underwent a euglycemic–hyperinsulinemic clamp
(4-h insulin infusion, 40 mUm2min1) using labeled
glucose infusates as reported in detail previously (Pedersen
et al. 2015; Kjobsted et al. 2016). In patients with T2D,
plasma glucose was allowed to decline to ~5.5 mmol L1
before glucose infusion was started. Using Steele’s non-
steady-state equations adapted for labeled glucose infusates,
we calculated total glucose disposal rates (GDR) for the last
30 min of the basal and the insulin-stimulated states (Ped-
ersen et al. 2015; Kjobsted et al. 2016). Distribution vol-
ume of glucose was taken as 200 mL kg1 body weight and
pool fraction as 0.65. After 4–8 weeks, the participants
returned after an overnight fast for the exercise day. After
they rested in the supine position for 30 min, the first mus-
cle biopsy (basal) from m. vastus lateralis was taken. Next,
the participants exercised on a cycle ergometer for 60 min
at an intensity of 70% of VO2max. Immediately after com-
pletion of exercise, a second skeletal muscle biopsy (exer-
cise) was obtained from the same leg 4–5 cm proximal to
the first biopsy site. Before obtaining the third biopsy (re-
covery) from m. vastus lateralis of the other leg, the partici-
pants rested in bed for 3-h. All the biopsies were obtained
using a modified Bergstr€om needle with suction under local
anesthesia (10 mL lidocaine 2%). The muscle biopsies were
immediately blotted free of visible blood and connective
tissue and frozen in liquid nitrogen (Kjobsted et al. 2016;
Kruse et al. 2016). Blood samples used for the study of
myokines were taken immediately prior to the exercise
bout, immediately after exercise and 3-h into recovery.
Plasma/serum samples were stored at 80°C until analysis.
Blood analysis
Plasma CHI3L1 was measured by the Micro Vue YKL-40
enzyme immunoassay from Quidel (San Diego, Ca)
Table 1. Clinical and metabolic characteristics of the participants.
Controls Type 2 diabetes
n 14 13
Age (years) 54.7  2.3 55.4  2.0
BMI (kg m2) 29.0  0.9 29.7  1.0
Fat free mass (kg) 69.1  2.4 68.3  2.0
Fat mass (kg) 24.5  1.9 28.2  2.4
Fasting plasma
glucose (mmol L1)
5.6  0.1 10.0  0.7***
HbA1c (%) 5.5  0.1 7.0  0.2***
Plasma triglycerides
(mmol L1)
1.5  0.2 3.2  1.5
IPAQ score 5248  952 5558  943
VO2max (L min
1) 3.50  0.2 3.22  0.2
GDR, clamp
(mg m2 min1)
349  35 242  35*
Diabetes duration
(years)
– 3.5  1.2
Data represent means  SEM. *P < 0.05 and ***P < 0.001 versus
controls.
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essentially as described by the manufacturer. According to
the manufacturer, lower limit of quantitation is 15.6 ng
mL1 and the between-run precision is 6–7% in a
CHI3L1 range from 51.8 to 262.9 ng mL1. Plasma IL-15
was measured by the Human IL-15 Quantikine sandwich
ELISA from Biotechne (RnD Systems, Minneapolis, MN)
essentially as described by the manufacturer. Minimal
detectable concentration was less than 2 pg mL1, and
interassay CV 6.6–9.1% (range 9.9–184 pg mL1). Plasma
ANGPTL4 was measured by using the Human ANGPTL4
DuoSet Elisa from Biotechne (Minneapolis, MN) essen-
tially as described by the manufacturer.
Plasma IL-6 was measured by the human IL-6 Quan-
tikine HS (high sensitivity) ELISA from Biotechne (Min-
neapolis, MN) essentially as described by the
manufacturer. According to the manufacturer, minimal
detectable concentration is 0.039 pg mL1, and interassay
CV 6.5–9.6% (range 0.49–5.65 pg mL1). Serum FGF-21
was measured by the Human FGF-21 ELISA assay from
BioVendor (Brno, Czech Republic) essentially as described
by the manufacturer. According to the manufacturer,
limit of detection is 7 pg mL1, and interassay CV 3.1–
3.5% (range 250–320 pg mL1).
RNA extraction, reverse transcription, and
quantitative real-time PCR
Total RNA was extracted from 50–75 mg of muscle as
previously described (Kristensen et al. 2014). cDNA syn-
thesis was performed using High Capacity cDNA Reverse
Transcription kit (Life Technologies/ Applied Biosystems,
Foster City, CA) according to manufacturer0s instructions.
Quantitative real-time PCR was performed on a 7900HT
Fast Real-Time PCR System (Applied Biosystems/Life
Technologies, Foster City, CA) using TaqMan Custom
Arrays (Life Technologies/Applied Biosystems, Foster City,
CA) according to the manufacturer0s instructions. Primers
used for quantitative real-time PCR analysis are listed in
Table S1. All samples were run in triplicates. Gene expres-
sion data was analysed using qBase+ Biogazelle software
(Zwijnaarde, Belgium)( Vandesompele et al. 2002; Helle-
mans et al. 2007) and normalized to the geometric mean
of two reference genes, peptidylprolyl isomerase A (PPIA)
and beta-2-microglobulin (B2M).
Statistical analyses
Statistical analyses were performed using SigmaPlot 13.0
software (Systat Software, San Jose, CA). Two-way
ANOVA with repeated measures, followed by Student-
Newman-Keul post hoc analysis were performed when
comparisons were made among groups. When no interac-
tion between groups was observed, the P-values report a
main effect. Correlation analyses were performed using
Spearman rank correlation coefficient. Data are expressed
as means  SEM. The significance level was accepted at
P < 0.05.
Results
Clinical characteristics
As reported before (Pedersen et al. 2015; Kjobsted et al.
2016; Kruse et al. 2016), HbA1c and plasma glucose
levels were significantly elevated in patients with T2D
compared with weight-matched controls, whereas no sig-
nificant differences in body composition, VO2max or
Wmax were observed. Insulin sensitivity measured as
insulin-stimulated GDR was reduced (~30%) in the dia-
betic group compared to the control group (Table 1)
(Pedersen et al. 2015; Kjobsted et al. 2016; Kruse et al.
2016).
Muscle expression and plasma levels of IL-6
and IL-15
Acute exercise robustly increased muscle IL6 mRNA level
(P < 0.001) in weight-matched controls and patients with
T2D compared with the basal levels, whereas 3-h into
recovery, expression of IL6 returned (main effect,
P < 0.001) to basal levels in both groups compared with
immediately after exercise (Fig. 1A). Plasma IL-6
increased (P < 0.001) ~200% in both groups immediately
after exercise, but then decreased toward basal levels 3-h
into recovery (P < 0.001), however, still being increased
(~2-fold) (P < 0.001) compared to basal levels (Fig. 1B).
Muscle expression of IL15 did not change in response to
acute exercise, but decreased slightly 3-h into recovery in
both groups compared with basal levels (P < 0.001) and
immediately after exercise (P < 0.001) (Fig. 1C). In con-
trast, plasma IL-15 increased (P < 0.001) modestly (19–
25%) in both groups immediately after exercise. Plasma
IL-15 decreased (P < 0.001) 3-h into recovery in both
groups compared with both basal values and immediately
after exercise (Fig. 1D). No significant differences in mus-
cle expression or plasma levels of IL-6 or IL-15 in
response to exercise or recovery were observed between
patients with T2D and weight-matched controls (Fig. 1A–
D).
Muscle expression and serum levels of
FGF21
Muscle expression of FGF21 increased (P = 0.019) in
response to acute exercise in both groups compared with
basal levels, and increased further 3-h into recovery
2018 | Vol. 6 | Iss. 12 | e13723
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compared with after exercise (P < 0.001) (Fig. 2A).
Serum FGF21 increased (P = 0.042) modestly (6–16%) in
response to exercise in both groups compared to basal
levels, but then declined (10–21%) to levels lower than
both after exercise (P < 0.001) and in the basal state
(P = 0.021) (Fig. 2B). Serum FGF21 was higher in
patients with T2D throughout the exercise study
(P < 0.001), but otherwise no significant differences in
expression of FGF21 or changes in muscle expression or
serum levels of FGF21 in response to exercise or recovery
were observed between patients with T2D and weight-
matched controls (Fig. 2).
Muscle expression and plasma levels of
ANGPTL4 and CHI3L1
Muscle expression of ANGPTL4 (P < 0.001) and CHI3L1
(P < 0.05) increased immediately after exercise in both
groups compared with basal levels, and both expression
of ANGPTL4 and CHI3L1 increased further 3-h into
A B
C D
Figure 1. Muscle expression and plasma levels of IL-6 and IL-15. (A) IL6 mRNA, (B) Plasma IL-6, (C) IL15 mRNA and (D) Plasma IL-15 in patients
with T2D (black bars, ∎) and healthy controls (white bars, s) before (Basal) and immediately after 60 min of exercise at 70% VO2max (Exercise)
and 3-h into recovery (3-h Rec.). Values are means  SEM. mRNA levels were measured in n = 13 controls and n = 10 patients with T2D.
***P < 0.001 versus Basal (main effect), and §§§P < 0.001 versus Exercise (main effect).
A B
Figure 2. Muscle expression and serum levels of FGF21. (A) FGF21 mRNA and (B) Plasma FGF-21in patients with T2D (black bars, ∎) and
healthy controls (white bars, s) before (Basal) and immediately after 60 min of exercise at 70% VO2max (Exercise) and 3-h into recovery (3-h
Rec.). Values are means  SEM. mRNA levels were measured in n = 13 controls and n = 10 patients with T2D. *P < 0.05 and ***P < 0.001
versus basal (main effect), §P < 0.05 and §§§P < 0.001 versus exercise (main effect), and ###P < 0.001 versus healthy controls (main effect).
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recovery compared with after exercise (both P < 0.001)
(Fig. 3A and C). In line, plasma ANGPTL4 increased
(P < 0.001) in response to acute exercise in both groups
compared with basal levels, and continued to increase 3-h
into recovery compared with after exercise (P < 0.001)
(Fig. 3B). In contrast, plasma CHI3L1 increased
(P < 0.001) only modestly (~9%) in response to acute
exercise in both groups, and then 3-h into recovery
declined to levels lower than both after exercise
(P < 0.001) and in the basal state (P < 0.001) (Fig. 3D).
Plasma CHI3L1 was higher in patients with T2D through-
out the exercise study (P < 0.05) (Fig. 3D), but otherwise
no significant differences in plasma ANGPTL4, muscle
expression of ANGPTL4 or CHI3L1, or exercise-induced
changes in expression or plasma levels of ANGPTL4 or
CHI3L1 were observed between patients with T2D and
weight-matched controls (Fig. 3A–D).
Muscle expression of CYR61 and CTGF
The muscle transcript levels of CYR61 and CTGF did not
differ between patients with T2D and weight-matched
controls either before, after an acute bout of exercise or
3-h into recovery (Fig. 4). However, acute exercise
robustly increased the expression of CYR61 (P < 0.001)
in both groups compared with basal levels, whereas mus-
cle expression of CTGF was only modestly increased
(P < 0.001) in response to exercise in both groups. Both
the expression of CYR61 and CTGF returned to basal
levels (P < 0.001) compared with after exercise. There
were no significant differences in the exercise-induced
changes in expression of CYR61 and CTGF between
patients with T2D and weight-matched controls.
Correlation analyses
Correlation analysis was performed to examine the poten-
tial relationship between muscle expression and circulat-
ing levels of myokines in response to acute exercise and
the influence of body composition and metabolic charac-
teristics in the total study cohort (n = 27). Interestingly,
we found no significant correlations between the muscle
transcript levels and the corresponding plasma/serum
levels of IL-6, IL-15, FGF21, or CHI3L1 either before,
immediately after exercise or 3-h into recovery, except for
a correlation between the expression of ANGPTL4 and
plasma levels of ANGPTL4 3-h into recovery (r = 0.436,
P = 0.02). Importantly, we found no significant correla-
tion between the exercise-induced changes in muscle
mRNA levels and the corresponding changes in plasma/
A B
C D
Figure 3. Muscle expression and plasma levels of ANGPTL4 and CHI3L1. (A) ANGPTL4 mRNA, (B) Plasma ANGPTL4, (C) CHI3L1 mRNA and (D)
Plasma CHI3L1 in patients with T2D (black bars, ∎) and healthy controls (white bars, s) before (Basal) and immediately after 60 min of exercise
at 70% VO2max (Exercise) and after 3-h into recovery (3-h Rec.). Values are means  SEM. mRNA levels were measured in n = 13 controls and
n = 11 patients with T2D. *P < 0.05 and ***P < 0.001 versus basal (main effect), §§§P < 0.001 versus exercise (main effect), and #P < 0.05
versus healthy controls (main effect).
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serum levels of IL-6, IL-15, FGF21, ANGPTL4, or
CHI3L1.
BMI and fat mass correlated inversely with the exer-
cise-induced muscle expression of CHI3L1 (r = 0.59,
P < 0.01), CYR61 (r = 0.44, P = 0.02), and CTGF
(r = 0.60, P < 0.01). Moreover, BMI correlated with
plasma IL-6 (r = 0.46, P = 0.02) and fat mass correlated
with basal plasma IL-6 (r = 0.48, P = 0.01) and serum
FGF21 throughout the study (r = 0.40–0.41, P < 0.05).
Fasting plasma glucose and HbA1c correlated with serum
FGF21 (r = 0.64–0.75, all P < 0.01) and plasma CHI3L1
(r = 0.41–0.52, all P < 0.05) before, immediately after
exercise and 3-h into recovery. Accordingly, insulin sensi-
tivity measured as insulin-stimulated Rd on a separate
day correlated inversely with serum FGF21 at all time
points on the exercise day (r = 0.40–0.49, all P < 0.05)
and inversely with plasma CHI3L1 (r = 0.40–0.42, all
P < 0.05) immediately after exercise and 3-h into recov-
ery. Plasma free fatty acids (FFA) before exercise corre-
lated positively with expression of ANGPTL4 (r = 0.59,
P < 0.01) before exercise and with the exercise-induced
expression of FGF21 (r = 0.44, P = 0.03) and ANGPTL4
(r = 0.47, P = 0.02), but inversely with the exercise-
induced expression of IL15 (r = 0.51, P < 0.01). Plasma
FFA 3-h into recovery correlated positively with muscle
expression of ANGPTL4 (r = 0.50, P = 0.02) at this time.
Discussion
In this study, we examined the effect of a moderate-inten-
sity exercise stimulus on the muscle mRNA levels and cir-
culating levels of selected myokines in patients with T2D
and weight-matched, glucose tolerant men. The novel
findings of this study are that patients with T2D show an
intact regulation of muscle gene expression and circulat-
ing levels of a panel of both well-established (IL-6) and
novel putative myokines (IL-15, FGF21, ANGPTL4,
CHI3L1, CYR61 and CTGF) in response to acute exercise.
Thus, the potential beneficial metabolic effects of the
exercise-mediated synthesis and release of these myokines
do not seem to be impaired in patients with T2D. How-
ever, the dissociated pattern of changes in muscle expres-
sion and circulating levels of some of these myokines (IL-
15, FGF21, ANGPTL4, CHI3L1) as well as the lack of cor-
relation between the changes in each of these myokines
after exercise and 3-h into recovery, emphasizes that fur-
ther studies are needed to establish the source and the
role of at least some of these exercise-induced myokines.
Several studies have reported that muscle mRNA and
circulating levels of IL-6 are increased in response to
acute exercise in healthy, lean and obese individuals
(Steensberg et al. 2000, 2001; Keller et al. 2003; Chris-
tiansen et al. 2013). Similarly, studies have demonstrated
that acute exercise increases circulating levels of IL-15 in
humans (Riechman et al. 2004; Tamura et al. 2011;
Christiansen et al. 2013), whereas the effect of acute exer-
cise on muscle expression of IL15 in humans is unclear
(Nieman et al. 2003, 2004; Louis et al. 2007). Consis-
tently, we here report an intact and robust increase in
muscle expression and circulating levels of IL-6 immedi-
ately after exercise in both patients with T2D and weight-
matched controls. Thus, the most well-established of the
examined myokines responded to acute exercise as
expected providing proof of principle with respect to
study design. As a novel finding, we demonstrate for the
first time an exercise-induced increase in circulating levels
of IL-15 in patients with T2D similar to the increase
observed in weight-matched controls. However, no
increase in muscle expression of IL15 was observed in
either group immediately after exercise, whereas muscle
expression of IL15 decreased 3-h into recovery. A previ-
ous study reported increased muscle mRNA levels of IL15
24-h after heavy bout of resistance exercise (Nielsen et al.
2007), emphasizing that the regulation of IL15 mRNA
levels and serum Il-15 may depend on the exercise type,
the athletic level of the individuals and timing of the
A B
Figure 4. Muscle expression of CYR61 and CTGF. (A) CYR61 mRNA and (B) CTGF mRNA in patients with T2D (black bars) and healthy controls
(white bars) before (Basal) and immediately after 60 min of exercise at 70% VO2max (Exercise) and after 3-h into recovery (3-h Rec.). Values are
means  SEM. mRNA levels were measured in n = 13 controls and n = 13 patients with T2D. ***P < 0.001 versus basal (main effect), and
§§§P < 0.001 versus exercise (main effect).
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muscle and blood samples in different studies (Pistilli and
Quinn 2013). The dissociated pattern of changes and the
lack of correlation between changes in muscle mRNA and
circulating levels of IL-15, suggest that muscle might not
be the major tissue responsible for elevated circulating
levels of IL-15 in response to acute exercise in humans.
Thus, further studies are needed to establish the putative
role of IL-15 as a myokine in humans.
FGF21 is an important regulator of glucose and lipid
metabolism and several studies have reported that muscle
expression and circulating FGF21 levels are increased by
acute exercise in mice and healthy humans (Fisher and
Maratos-Flier 2016; Tanimura et al. 2016), although in
one study of mice the exercise-induced increase in plasma
FGF21 was not accompanied by increased muscle expres-
sion of FGF21 (Kim et al. 2013). It was recently reported
that the exercise-induced (60 min at 50% of VO2max)
increase in plasma FGF21 was absent in a small cohort of
patients with T2D, when evaluated as the fold-change rel-
ative to baseline levels (Hansen et al. 2016). However, in
neither non-obese patients with T2D nor obese/over-
weight controls, exercise changed plasma FGF21 levels
when analysed in absolute concentrations (Hansen et al.
2016). In contrast, we investigated a larger cohort of
patients with T2D and weight-matched controls and were
able to demonstrate both increased muscle expression and
elevated circulating levels of FGF21 in humans in
response to acute exercise. Moreover, we for the first time
demonstrate that both these responses to acute exercise
are intact in patients with T2D. Nevertheless, the exer-
cise-induced changes in muscle FGF21 mRNA expression
were dissociated from the changes in serum FGF21 as evi-
denced by a continued increase in muscle FGF21 expres-
sion despite a marked reduction in serum FGF21 levels 3-
h into recovery. This, together with the lack of correlation
between exercise-induced changes in muscle expression
and serum levels of FGF21, indicates that tissues other
than skeletal muscle are responsible for the regulation of
circulating FGF21 in response to exercise. This is sup-
ported by recent studies of mice and humans, which have
provided evidence that the liver is a major contributor to
the exercise-induced increase in circulating FGF21 (Kim
et al. 2013; Hansen et al. 2016; Tanimura et al. 2016).
The role of FGF21 as a myokine was first suggested by
experimental work showing increased muscle expression
and release of FGF21 in Akt1 overexpressing mice (Izu-
miya et al. 2008). This was supported by studies showing
increased muscle expression and serum FGF21 levels in
response to physiological concentrations of insulin in
humans (Hojman et al. 2009; Kruse et al. 2017). How-
ever, as reported previously (Kjobsted et al. 2016), serum
insulin levels declined ~50% immediately after exercise in
our study, supporting that the increase in circulating
FGF21 in response to acute exercise does not originate
from skeletal muscle but rather from the liver, where it
seems to be mediated by an elevated glucagon-to-insulin
ratio (Hansen et al. 2015a).
ANGPTL4 is a potent inhibitor of LPL activity and reg-
ulator of lipid metabolism (Grootaert et al. 2012). In
agreement with previous exercise studies in nondiabetic
individuals (Kersten et al. 2009; Catoire et al. 2014a,b;
Norheim et al. 2014; Ingerslev et al. 2017), we are the
first to demonstrate an intact upregulation of muscle
ANGPTL4 mRNA and increase in circulating ANGPTL4
in response to acute exercise and further 3-h into recov-
ery in patients with T2D. Experimental work in mice and
humans have provided evidence that exercise markedly
induces expression of ANGPTL4 in both adipose tissue
and liver, and that ANGPTL4 is mainly released from the
liver in response to exercise (Norheim et al. 2014; Inger-
slev et al. 2017). These data suggest that other tissues
may contribute more than skeletal muscle to the exercise-
induced increase in circulating ANGPTL4. Although we
observed a similar pattern of changes in muscle expres-
sion and circulating levels of ANGPTL4, we found no
correlation between these changes, which supports the
hypothesis that muscle is not the major source of plasma
ANGPTL4 in response to exercise (Catoire et al. 2014a).
Several studies have indicated that increased circulating
ANGPTL4 levels are mediated by elevation in plasma FFA
(Kersten et al. 2009; Catoire et al. 2014b; Norheim et al.
2014). We have previously reported that exercise caused
increased plasma FFA, which was further elevated 3-h
into recovery in this study cohort (Pedersen et al. 2015).
This suggests that increased plasma FFA mediated the
increased muscle expression and circulating levels of
ANGPTL4. In agreement, correlation analyses showed
that muscle expression of ANGPTL4 was positively associ-
ated with FFA before exercise and 3-h into recovery,
although not immediately after exercise. Nevertheless, fur-
ther studies are necessary to understand the regulation
and role of changes in circulating ANGPTL4 during
exercise.
In cultured human skeletal muscle cells, CHI3L1 has
been shown to protect against TNF-a mediated inflamma-
tion and insulin resistance and to promote muscle growth
and repair (Gorgens et al. 2014). In line with a previous
study reporting an exercise-induced increase in muscle
expression and circulating levels of CHI3L1 in non-dia-
betic individuals (Gorgens et al. 2016), we here, for the
first time, demonstrate an intact exercise-induced increase
in muscle expression of CHI3L1, in particular 3-h into
recovery, in patients with T2D, as well as an intact but
only modest and transient increase in circulating CHI3L1.
The dissociated pattern of changes and the lack of corre-
lation between changes in muscle mRNA and circulating
2018 | Vol. 6 | Iss. 12 | e13723
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levels of CHI3L1 suggest that circulating CHI3L1 is not
regulated by changes in muscle expression of this pre-
sumed myokine. IL-6 or TNF-a might regulate CHI3L1
as suggested by Gorgens et al. (2014). However, we did
not identify any association between either muscle mRNA
and circulating levels of CHI3L1 and IL-6 at any time-
points or when comparing changes induced by exercise.
In the present study, we observed elevated circulating
levels of FGF21 and CHI3L1 in patients with T2D not
only in the basal, resting state but also during the exer-
cise study. Moreover, circulating FGF21 and CHI3L1
correlated positively with fasting plasma glucose and
HbA1c, but inversely with insulin sensitivity in the total
study cohort. These findings are consistent with several
other studies, which has demonstrated elevated circulat-
ing levels of FGF21 and CHI3L1 in patients T2D (Niel-
sen et al. 2008; Chavez et al. 2009; Cheng et al. 2011;
Kruse et al. 2017). However, in contrast to our hypothe-
sis, these alterations did not attenuate the exercise-
induced regulation of these myokines in the muscle or
the circulation. Circulating levels of ANGPTL4 has been
reported to be both elevated (Tjeerdema et al. 2014) and
reduced in patients with T2D (Xu et al. 2005), which
could be explained by the interindividual variability in
ANGPTL4 levels (Kersten et al. 2009). However, we
observed no differences in plasma ANGPTL4 levels
between patients with T2D and weight-matched individ-
uals in our study. Interestingly, we showed that plasma
IL-6 correlates strongly with BMI and fat mass, suggest-
ing that IL-6 levels are strongly associated with over-
weight/obesity, which is supported by other studies
(Khaodhiar et al. 2004).
ECM associated proteins such as CYR61 and CTGF are
important players in regulating endothelial function and
angiogenesis (Perbal 2004). Recently, secretome analysis
of muscle transcripts that changed in response acute exer-
cise, suggested CYR61 and CTGF as exercise-induced
putative myokines that are likely to be secreted from
human skeletal muscle (Catoire et al. 2014a). Moreover,
microarray analysis showed a similar exercise-induced
increase in muscle CTGF expression in non-obese patients
with T2D and overweight controls (Hansen et al. 2015b).
In accordance with these findings (Catoire et al. 2014a;
Hansen et al. 2015b), we observed an immediate and
equal increase in muscle gene expression of CYR61 and
CTGF in response to exercise in patients with T2D and
weight-matched groups. However, plasma levels of CYR61
did not change in response to acute exercise in healthy
humans (Catoire et al. 2014a), suggesting that these puta-
tive myokines may act only locally on muscle cells.
The limitations of our study include a small study
cohort, the lack of a lean, healthy group to exclude the
possibility that obesity/overweight itself causes exercise
resistance, as well as lack of inclusion of women in both
study groups in order to rule out gender-specific effects
of exercise on the examined myokines. Moreover, access
to adipose tissue biopsies as well as the application of
measurements of the arterial-to-venous difference over
the leg and the hepato-splanchnic bed would have been
helpful to determine the origin of the examined myokines
in response to exercise (Hansen et al. 2016; Ingerslev
et al. 2017).
In summary, our study provides novel evidence that
the effects of an acute bout of exercise on muscle gene
expression and circulating levels of selected well-estab-
lished and novel putative myokines are intact in patients
with T2D compared with weight-matched controls. Thus,
the potential beneficial metabolic effect of the exercise-
induced elevation in the circulating levels of these puta-
tive myokines does not seem to be attenuated in patients
with T2D. However, the dissociation in patterns of exer-
cise-induced changes in muscle expression and circulating
levels of these myokines indicate that other organs may
contribute more than muscle to the exercise-induced
changes in circulating levels of these presumed myokines,
and that the contraction-mediated increase in muscle
expression of at least some of these myokines may play a
more local role, regulating muscle adaptation to exercise
in an autocrine manner.
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